EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives

Alizée Allamand iD, Teresa Piechowiak, Didier Lièvremont, Michel Rohmer iD, Catherine Grosdemange-Billiard

Molecules · 01.02.2023 · 28 (3) · 1403

DOI: 10.3390/molecules28031403 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 01.02.2023. Verfasst von Alizée Allamand und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire de Chimie et Biochimie de Molécules Bioactives-Université de Strasbourg/CNRS, UMR 7177, Institut Le Bel, 4 Rue Blaise Pascal, 67081 Stras…. Hauptthemen laut MEDLINE: Sugar Phosphates. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 138 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Isoprenoids, a diverse class of natural products, are present in all living organisms. Their two universal building blocks are synthesized via two independent pathways: the mevalonate pathway and the 2-C-methyl-ᴅ-erythritol 4-phosphate (MEP) pathway. The presence of the latter in pathogenic bacteria and its absence in humans make all its enzymes suitable targets for the development of novel antibacterial drugs. (E)-4-Hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP), the last intermediate of this pathway, is a natural ligand for the human Vγ9Vδ2 T cells and the most potent natural phosphoantigen known to date. Moreover, 5-hydroxypentane-2,3-dione, a metabolite produced by Escherichia coli 1-deoxy-ᴅ-xylulose 5-phosphate synthase (DXS), the first enzyme of the MEP pathway, structurally resembles (S)-4,5-dihydroxy-2,3-pentanedione, a signal molecule implied in bacterial cell communication. In this review, we shed light on the diversity of potential uses of the MEP pathway in antibacterial therapies, starting with an overview of the antibacterials developed for each of its enzymes. Then, we provide insight into HMBPP, its synthetic analogs, and their prodrugs. Finally, we discuss the potential contribution of the MEP pathway to quorum sensing mechanisms. The MEP pathway, providing simultaneously antibacterial drug targets and potent immunostimulants, coupled with its potential role in bacterial cell–cell communication, opens new therapeutic perspectives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sugar PhosphatesHumansTerpenesAnti-Bacterial AgentsErythritol

Stichwörter der Autor:innen

MEP pathwayantibacterial drugimmunostimulantisoprenoidslaurencionephosphoantigenprodrugquorum sensing

Substanzen

2-C-methylerythritol 4-phosphateSugar PhosphatesTerpenesAnti-Bacterial AgentsErythritol

Autor:innen und Institutionen

  • Laboratoire de Chimie et Biochimie de Molécules Bioactives-Université de Strasbourg/CNRS, UMR 7177, Institut Le Bel, 4 Rue Blaise Pascal, 67081 Strasbourg, France.
  • Unité de Chimie des Biomolécules, Institut Pasteur, Université Paris Cité, CNRS UMR3523, 75724 Paris, France.

ORCID-Profile: Alizée Allamand, Michel Rohmer

Zitieren

APA

Allamand, A., Piechowiak, T., Lièvremont, D., Rohmer, M., & Grosdemange-Billiard, C. (2023). The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives. Molecules, 28(3), 1403. https://doi.org/10.3390/molecules28031403

Vancouver

Allamand A, Piechowiak T, Lièvremont D, Rohmer M, Grosdemange-Billiard C. The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives. Molecules. 2023;28(3):1403. doi:10.3390/molecules28031403

BibTeX
@article{Allamand2023,
  author = {Allamand, Alizée and Piechowiak, Teresa and Lièvremont, Didier and Rohmer, Michel and Grosdemange-Billiard, Catherine},
  title = {The Multifaceted MEP Pathway: Towards New Therapeutic Perspectives},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {3},
  pages = {1403},
  doi = {10.3390/molecules28031403}
}
Kostenlos starten →